首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Future Medicinal Chemistry

Future Medicinal Chemistry杂志,由Future Science出版,于2009年创刊,Monthly,出版语言English,ISSN:1756-8919,E-ISSN:1756-8927。

投稿咨询
Future Medicinal Chemistry
Future Medicinal Chemistry
Future Medicinal Chemistry
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
3.3
CiteScore
4.4
期刊收录
SCI、SCIE

Future Medicinal Chemistry(中文译名:《未来药物化学》),ISSN:1756-8919,EISSN:1756-8927,是Future Science出版的国际性学术期刊,创刊于2009年,以Monthly形式稳定发行,2026年总发文量约189篇。该刊采用非OA开放访问,学科归属为CHEMISTRY, MEDICINAL。该刊是医学、药物化学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.3,2025年期刊CiteScore为4.4,2025年期刊自引率约3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Future Medicinal Chemistry长期聚焦医学、药物化学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药物化学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Italy、India、Egypt、Spain、England等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CHEMISTRY, MEDICINAL 药物化学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 41 / 72

43.8

学科:CHEMISTRY, MEDICINAL SCIE Q3 42 / 72

42.36

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 36 / 72

50.7

学科:CHEMISTRY, MEDICINAL SCIE Q3 42 / 72

42.36


中国学者近期发文

1
Modulating human IAPP aggregation in type 2 diabetes: inhibitors, mechanisms, and translational challenge

Author:Shi, Kaiwen; Jin, Jia; Zhang, Kui; Guo, Siqi; Ye, Fei

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. 18, Issue 8, pp. 979-991. DOI: 10.1080/17568919.2026.2636492

2
Discovery of novel 2,4-diarylaminopyrimidine derivatives as FAK inhibitors with potent anti-cancer potenc

Author:Lv, Yu-Zheng; Song, Jian; Zhang, Sai-Yang; Xu, Yan; Xi, Shou-Min

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2648996

3
Synergistic action of JNK activation and BChE inhibition: a novel anti- glioblastoma compound with neuroprotective profil

Author:Lu, Ziyao; Liao, Qinghong; Duan, Yuetong; Wang, Kaixuan; He, Siyu; Lyu, Weiping; Chen, Xuehong; Li, Qi

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2658833

4
Cyclization, amino acid coupling, docking-based virtual screening and SAR: showing a strategy of the structural modification for salvianic acid

Author:Wu, Jianhui; Zhang, Xiaoyi; An, Wenshuo; Yang, Yifan; Zhang, Peiwen; Wang, Yaonan; Zhao, Shurui; Feng, Qiqi; Zhao, Ming; Peng, Shiqi

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2658836

5
Overview of recent strategic advances in antiviral covalent inhibitor

Author:Wang, Bo; Wang, Siyuan; Zhang, Jiwei; Kim, Meehyein; Zhan, Peng

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642579

6
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activit

Author:Li, Xuhong; Liang, Yan; Zhang, Xiaoyu; Wu, Yongsheng; Wu, Tizhi; Tian, Yucheng; Tang, Cheng; Qiu, Zhixia; Wu, Hongxi; Bian, Jinlei; Li, Zhiyu; Xu, Xi; Wang, Jubo

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642584

7
Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitor

Author:Shao, Wu-Bin; Zhou, Xiang; Yang, Song; Zhou, Ying

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2642580

8
Recent advances in the design and development of small molecules targeting the TLR4 signaling pathwa

Author:Ishfaq, Muhammad; Shahab, Muhammad; Jiang, Guosong

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2648983

9
Design, synthesis and antitumor activity evaluation of 1,4-naphthoquinone-benzene sulfonamide hybrid

Author:Wei, Gang; Fan, Zi-Han; Huang, Ri-Zhen; Wei, Yi; Lei, Yu-Ban; Zhang, Bao-Qi; Tang, Yan; Luo, Li; Wang, Heng-Shan; Jiang, Jing-Chen; Li, Mei-Shan

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2628558

10
Targeting the cGAS-STING-TBK1 pathway in cancer therap

Author:Jiang, Leyao; Zhong, Ying; Zhang, Zilong; Yang, Qichen; Sun, Shengting; Sun, Huiqi; Liu, Zongliang

Journal: FUTURE MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/17568919.2026.2628553


在线咨询

Future Medicinal Chemistry

国际简称:FUTURE MED CHEM参考译名:未来药物化学

年发文量:189 CiteScore:4.4 是否预警:否 Gold OA文章占比:2.30% 研究类文章占比:60.32%

杂志社联系方式:FUTURE SCI LTD, UNITED HOUSE, 2 ALBERT PL, LONDON, ENGLAND, N3 1QB

Future Medicinal Chemistry